Phase Ib/II Clinical Study of QLS1304 Combined With Endocrine Therapy in the Treatment of ER+/HER2- Breast Cancer Patients
Clinical trial NCT07235176 · RECRUITING
Trial details
- NCT number
- NCT07235176
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-16
- Primary completion
- 2028-11-02
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.